Here at ePASS Recruit, we understand the importance of research in bringing about a solution for patients suffering from the ever-growing ailments that inflict the human body. It is our mission to successfully match patients with quality research, all in hopes of finding better treatment alternatives and improving lives.
We know that our work would be impossible without volunteers such as yourself and we thank you for helping us in our search for potential health solutions.
Together, we can make a difference.
Phase 0 Very Small. Around 10-20 patients Testing in very small doses. Initial exploratory testing. Often not used.
Phase I Small. Around 20-50 patients Testing in small doses to determine the effects of the substance on the human body and how safe it is.Phase II Medium. Can be up to 100 patients TTesting by using best and safest dose found in Phase I. Used to find out how effective the substance is on the human body.
Phase III Large. Can be up to hundreds or thousands of patients Testing on larger population. Also used to find how effective a substance is, often against an existing treatment.
Phase IV Medium to Large. Depending on the study Testing on a large population after approval and on the market. Used to further study the effectiveness and safety of a substance. Often not used.
Clinical trials often have inclusion criteria that determine who can volunteer for that study. These can include age, gender, and physical aspects of the patient. Sometimes they will ask for people with specific medical conditions and other times for people who are altogether healthy. Studies can also have exclusion criteria, such as smoking or pregnancy. These criteria ensure that the proper volunteers can be identified and that the study can be done appropriately and safely.
Please check below to see our studies list.
If eligible, please contact us to setup a preliminary screening at one of the study locations.
You should always check with your Primary Care Physician (PCP) before entering a clinical trial.
Once you enter a clinical trial, you are entitled to basic rights regarding your health and your information. The trial staff is obligated to discuss with you the purpose, procedures, risks, discomforts, side effects, and benefits of the study. You may refuse treatment at any time, and you may end participation in the trial at any time. Information and options in case of injury must be fully explained to you.
The clinical trial staff also must ensure that your identity and information is also protected in accordance to federal law. The trial must detail how they will handle any and all such data to ensure that the information remains private.
Trial participation can only take place after you have become fully informed about the study, and provide your informed consent.
FDA: What is Informed Consent?
Phase 1 Study of BRE-AD01 in Patients with Severe Atopic Dermatits (Skin Rashes)
[Description]
A Randomized, Parallel-group, Multi-center Phase 1 Study to Evaluate the Efficacy and Safety of BRE-AD01 in Patients with Severe Atopic Dermatitis
Please click here to learn more about this trial and see if you are eligible.
Phase 2 Study of CartiLife® in Articular Cartilage Defects
[Description]
A Multi-Center, Active-Controlled, Open-Label, Phase 2 Trial to Compare the Efficacy and Safety of CartiLife®, and Microfracture for Patients with Articular Cartilage Defects in the Knee
Please click here to learn more about this trial and see if you are eligible.